PT - JOURNAL ARTICLE AU - Fontana, Thomas JK AU - Schulz, Jonathan A. AU - Budney, Alan J. AU - Villanti, Andrea C. TI - Feasibility and Utility of a Structured Guide for Cannabis Tolerance Breaks in Young Adults AID - 10.1101/2022.05.18.22274748 DP - 2022 Jan 01 TA - medRxiv PG - 2022.05.18.22274748 4099 - http://medrxiv.org/content/early/2022/05/23/2022.05.18.22274748.short 4100 - http://medrxiv.org/content/early/2022/05/23/2022.05.18.22274748.full AB - Objective To explore the feasibility and utility of a tolerance break (T-Break) guide on young adults’ cannabis use.Participants Young adults aged 18-29 (n=125) who were current cannabis users.Methods Participants recruited through posters and listservs at various universities were offered the T-Break Guide—daily activities, advice, and encouragement—to help complete a 21-day cannabis break. Bivariate analyses examined associations between Guide use and follow-up measures.Results Compared to non-Guide users, participants who used the Guide “a lot” were more likely to complete the 21-day abstinence break (84% vs. 57%), revise their personal definition of balance to mean less cannabis (84% vs. 62%), and plan a future break (32% vs. 11%).Conclusion Use of this self-directed Guide may help young adults take a break from cannabis use and reduce future use. Further research using more rigorous designs to test the Guide’s efficacy and assess longer-term maintenance of effects is needed.Competing Interest StatementThis research was funded by a grant from the State of Vermont (TF). Effort of the authors was also supported by the National Institute on Drug Abuse of the National Institutes of Health under award numbers U54DA036114 (JAS), R21DA051943 (ACV), and P30DA029926 (AJB). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the State of Vermont. TF is the owner of Cum Laude Consulting LLC, which received a grant from the State of Vermont to investigate the T-Break Guide. Those funds were then subcontracted to the University of Vermont for this research.Clinical TrialNCT05382273Funding StatementThis research was funded by a grant from the State of Vermont (TF). Effort of the authors was also supported by the National Institute on Drug Abuse of the National Institutes of Health under award numbers U54DA036114 (JAS), R21DA051943 (ACV), and P30DA029926 (AJB). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the State of Vermont.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of University of Vermont gave ethical approval for this work (STUDY00001489)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced are available online at https://doi.org/10.7910/DVN/RQZQ1Q https://doi.org/10.7910/DVN/RQZQ1Q